Compare CNSP & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNSP | MGRX |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 7.1M |
| IPO Year | 2019 | 2023 |
| Metric | CNSP | MGRX |
|---|---|---|
| Price | $4.75 | $0.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.3K | ★ 522.9K |
| Earning Date | 11-16-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.03 | ★ 55.17 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $456,021.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.90 | $0.26 |
| 52 Week High | $10.54 | $2.50 |
| Indicator | CNSP | MGRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.40 | 30.62 |
| Support Level | $4.68 | N/A |
| Resistance Level | $5.52 | $0.49 |
| Average True Range (ATR) | 0.25 | 0.04 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 50.66 | 4.53 |
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.